|
2021
|
Invention
|
Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biol... |
|
|
Invention
|
Compositions, systems, and methods for generating gene-edited cells.
The present invention relat... |
|
|
Invention
|
Compositions, systems, and methods for generating gene-edited cells. The present invention relate... |
|
2020
|
Invention
|
Inhibition of innate immune response.
The present invention provides methods, kits, and composit... |
|
2019
|
Invention
|
Treatment of infections and immune dysregulation in patients with primary immune deficiencies usi... |
|
2017
|
Invention
|
Inhibition of innate immune response. The present invention provides methods, kits, and compositi... |
|
2015
|
Invention
|
Kits and methods for generating 5′ capped rna. The present invention relates to kits and methods ... |
|
2012
|
Invention
|
Compositions and methods for reprogramming mammalian cells.
The present invention relates to met... |
|
2011
|
Invention
|
Synthesis of tagged nucleic acids. The present invention relates generally to methods, compositio... |
|
2009
|
Invention
|
Rna polyphosphatase compositions, kits, and uses thereof. The present invention relates to the di... |
|
2007
|
Invention
|
Kits and methods for generating 5' capped rna.
The present invention relates to kits and methods... |
|
|
Invention
|
Kits and methods for generating 5' capped rna. The present invention relates to kits and methods ... |
|
2005
|
Invention
|
Selective terminal tagging of nucleic acids. Methods are provided for adding a terminal sequence ... |
|
2004
|
Invention
|
Selective terminal tagging of nucleic acids.
A method is provided for adding a terminal sequence... |
